Title Credit Activity type Target audience Start and expiration datessort descending
New Considerations for the Treatment of Glioblastoma Multiforme: Evaluating the Potential for Immune Checkpoint Inhibitors
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Non-physician credits
Webcast 01/18/2017 to 01/17/2018
Real-world Experience With Neuromuscular Blockade Reversal
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Webcast 06/09/2017 to 06/08/2018